Chronic lower back pain (CLBP)
is a part of the daily life for many veterans.

Those brave enough to have served and dedicated their lives to their country are not searching for another medication prescription to treat CLBP. They need a clinically proven VR therapy.

Talk to your doctor about how you can take control of your CLBP with the RelieVRx program.

The first FDA-authorized VR treatment proven to significantly reduce pain3,4

VR treatment that empowers you to manage your pain from the comfort of your home5

brain icon

Helps you recognize and adjust your cognitive, emotional, and physical responses to pain6

in-home icon

An easy-to-use, in-home therapy with minimal side effects that can be used with your other treatments4

calendar icon

Guides you through engaging sessions that take an average of 6 minutes a day to complete4

vr headset

The RelieVRx program demonstrated proven pain relief that lasts4,7

  • Clinically significant reduction in pain intensity was seen in a 56 session treatment study, with an average of 43% reduction compared to 25% for the placebo group.4
  • At 18 months post treatment with RelieVRx program, study participants continue to demonstrate significant reduction in pain intensity and pain interference with activity, mood, sleep and stress7
LEARN MORE

Get started today—provide these details to your healthcare provider

This information is for healthcare provider and purchasing agent use only. If you are a patient, please provide this information to your healthcare provider.

Contract Vehicles
  • Part # RVX-2002
  • GSA Contract # SPE2DE22DA020
  • FSS Contract # V797D-50450
Contact Info
  • customerservice@lovellgov.com
  • Phone: 850-684-1867
  • Fax: 850-254-9853
  • Order online: GSAadvantage.gov

If you are a current RelieVRx patient

and need support, call us at 1 (844) 728-4487
Monday through Friday, 9am-7pm ET

EMAIL US

Indication for Use

The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.

Contraindications

There are no known contraindications.

Warnings

People using the RelieVRx program may or may not experience motion sickness, dizziness, headache, or eye strain when using the device. If these experiences occur, please stop use of the device and resume therapy per your doctor’s advice.

References

  1. Kesiena O, Ajavi KV, Rene A, Benden M. Sociodemographic and work-related predictors of chronic lower back pain in the United States: the 2018 National Health Interview Survey data. Public Health. 2021;198:30-34.
  2. Belitskaya-Levy I, Clark JD, Shih MC, Bair MJ. Treatment preferences for chronic low back pain: views of veterans and their providers. J Pain Res. 2021;14:161-171.
  3. Park A. FDA gains first approval for a VR system to treat chronic lower back pain. Fierce Biotech. November 17, 2021. Accessed December 9, 2022. https://www.fiercebiotech.com/medtech/appliedvr-nets-fda-s-first-approval-for-a-vr-system-to-treat-chronic-low-back-pain.
  4. Garcia LM, Birkhead BJ, Krishnamurthy P, et al. An 8-week self-administered at-home behaviorial skills-based virtual reality program for chronic low back pain: double-blind, randomized, placebo-controlled trial conducted during COVID-19. J Med Internet Res. 2021;23(2):e26292.
  5. RelieVRx User [instructions for use]. Van Nuys, CA: AppliedVR, Inc; 2022.
  6. Hoffman HG, Richards TL, Coda B, et al. Modulation of thermal pain-related brain activity with virtual reality: evidence from fMRI. Neuroreport. 2004;15(8):1245-1248.
  7. Maddox T, Garcia H, Ffrench K, Maddox R, Garcia L, Krishnamurthy P, Okhotin D, Sparks C, Oldstone L, Birckhead B, Sackman J, Mackey I, Louis R, Salmasi V, Oyao A, Darnall BD. In-home virtual reality program for chronic low back pain: durability of a randomized, placebo-controlled clinical trial to 18 months post-treatment. Reg Anesth Pain Med. 2022 Nov 25:rapm-2022-104093.